Skip to main content
OpenTrials

Clinical trial condition

Chronic Urticaria

Explore clinical trials studying Chronic Urticaria. Study availability and eligibility vary by location and protocol.

139 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Chronic Urticaria trial results

Completed

A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines

NCT03580369

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Gilbert, Arizona, United States
  • Novartis Investigative Site Litchfield Park, Arizona, United States
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
View all 161 locations
View Trial Details
Completed

A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

NCT04538794

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Arizona Allergy & Immunology Research Gilbert, Arizona, United States
  • Sarasota Clinical Research Sarasota, Florida, United States
  • ForCare Clinical Research Tampa, Florida, United States
View all 14 locations
View Trial Details
Completed

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

NCT03926611

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Litchfield Park, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Mission Viejo, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 82 locations
View Trial Details
Completed

Dupilumab in Chronic Spontaneous Urticaria

NCT03749135

Conditions
Angioedema, Cardiovascular Diseases, Chronic Disease, +17 more
Locations
  • Universitätsklinikum Giessen und Marburg Marburg, Hesse, Germany
  • Hautklinik Universitätsklinikum Münster Münster, NRW, Germany, Germany
  • Hautklinik der Universitätsmedizin Mainz Clinical Research Center Mainz, Rheinland-Pfalz, Germany, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden, Saxony, Germany
View Trial Details
Completed

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

NCT02649218

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +20 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Scottsdale, Arizona, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Sarasota, Florida, United States
View all 67 locations
View Trial Details

Related conditions